Dr. Chu's clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.

The Yang lab's research seeks to understand how microenvironmental cues regulate stem cell fate, and to develop novel biomaterials and stem cell-based therapeutics for tissue engineering and regenerative medicine.

The Xing lab's vision is to be a premier laboratory of medical imaging, physics and engineering in the world committed to excellence and innovation in both scientific research and technical development.

Dr. Xia's research group is interested in the design, synthesis, and manipulation of macromolecules and soft materials with unique functions, conformations, and interactions.

Dr. Wu's lab seeks to identify mechanisms regulating cardiac lineage commitment during embryonic development and the biology of cardiac progenitor cells in development and disease.

Dr. Wu's laboratory focuses on the mechanisms guiding the differentiation of mesenchymal stem cells, and how mesenchymal lineages support hematopoiesis in the bone marrow.

The biological question that is driving the Wysocka lab's research in the long-term is understanding the epigenetic basis of vertebrate development and differentiation.

Dr. Chu's laboratory focuses on understanding how cells respond to DNA damage.

Dr. Chichilnisky's laboratory focuses on the study of retinal ganglion cells, which are the output neurons of the retina that send visual information to the brain in their spatio-temporal patterns of electrical activity.

The goal of the Winslow lab is to use unbiased genomic methods and in vivo models to better understanding the molecular and cellular changes that underlie tumor progression and each step of the metastatic cascade.